Timed OX1R/OX2R antagonism during the rest phase may consolidate sleep, improve glymphatic/interstitial clearance, and reduce amyloid or tau stress while avoiding daytime cognitive suppression. The therapeutic effect should depend on circadian timing.
Curated pathway from expert analysis
flowchart TD A["Night-phase OX1R/OX2R Antagonism"] -->|"Restores sleep architecture"| B["Sleep Consolidation"] A -->|"Target: HCRTR2"| C["Orexin Signaling Suppression"] C -->|"Disinhibition of NREM sleep"| B B -->|"Enhances convective flow"| D["Glymphatic Clearance Activation"] D -->|"Increases ISF drainage"| E["Interstitial A-beta Reduction"] D -->|"Clears metabolite waste"| F["Tau Phosphorylation Decrease"] E -->|"Reduces seeding events"| F F -->|"Prevents neurofibrillary tangle formation"| G["Synaptic Protection"] A -->|"Avoids daytime orexin blockade"| H["Preserved Daytime Cognition"] G -->|"Maintains neuronal signaling"| I["Cognitive Function Rescue"] H -->|"No executive suppression"| I E -->|"Decreases amyloid plaque burden"| I G -->|"Prevents progressive neurodegeneration"| J["AD Pathology Attenuation"] I -->|"Clinical benefit"| K["Memory Improvement"] K -->|"Therapeutic outcome"| L["Disease Modification"]
No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for HCRTR2 yet. Search RCSB →
Median TPM across 13 brain regions for HCRTR2 from GTEx v10.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for HCRTR2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.